Role purpose AstraZenecas bold ambition is to be a pioneer in science, lead in our disease areas and transform patient outcomes — and by 2030, to deliver 20 new medicines and industry‑leading growth. Biologics are central
Attendance as a Vital Sign (AVS) is a cross-sector national program focused on the health and social drivers of chronic absence, helping state and local-level actors improve the conditions for local success. We are seeking an